Supplemental material, sj-csv-2-onc-10.1177_11795549231203142 for Clinical Features and Outcomes of Primary Breast Diffuse Large B-Cell Lymphoma: A Matched-Pair Study by Ling-Chiao Teng, Yu-Min Liao,
RationalWhile a variety of registered therapies exist for Cutaneous T Cell Lymphoma, no such therapy is available for Cutaneous B Cell Therapy. In this context we performed a phase II, open label, mul
In 2023, malignant neoplasms were the leading cause of death among the female population in Japan at around 161.1 thousand deaths. This number accounted for about 21 percent of approximately 773.5 tho